Ozempic linked with lower dementia risk, nicotine use, British study finds

Ozempic could lower risk of cognitive problems, new study shows - Washington Examiner

The popular diabetes drug Ozempic could be linked to a lower risk of cognitive problems, according to a new study conducted by researchers at the University of Oxford. The study analyzed more than 100 million patient records in the United States, including over 20,000 who were taking semaglutide — commonly known as Ozempic or Wegovy. It found that semaglutide was not associated with an increased risk of neurological and psychological conditions,…

Ozempic linked to lower dementia rate in Oxford study

Novo is also studying the drug as a treatment for Alzheimer’s in two large trials due to deliver results next year.

Ozempic could cut risk of dementia in half, Oxford study finds

Results suggest the weight-loss drug may also be protective against addiction

Ozempic Linked With Lower Dementia Risk, Nicotine Use, British Study Finds

US News is a recognized leader in college, grad school, hospital, mutual fund, and car rankings. Track elected officials, research health conditions, and find news you can use in politics, business, health, and education.

Ozempic may reduce dementia: Research

Ozempic use is associated with a lowered risk for cognitive problems, researchers in a new study said. The findings, however, cannot be applied to users who do not have diabetes. The study, published Thursday, was conducted by researchers from the University of Oxford who analyzed more than 100,000 U.S. patient records, including 20,000 who were…

Ozempic linked with lower dementia risk, nicotine use, British study finds

Novo Nordisk's popular diabetes treatment Ozempic could be tied to a lower risk of cognitive problems, according to an observational study published by researchers at Oxford University.